| Next |
Ad
PSTV Message Board | PLUS THERAPEUTICS Inc.
home / stock / pstv / pstv message board
Message Board | PLUS THERAPEUTICS Inc. (NYSE:PSTV)
| Subject | By | Source | When |
|---|---|---|---|
| The company more than likely will announce a | Sierra20 | investorshub | 04/20/2023 4:52:51 AM |
| NEWS -- Plus Therapeutics Completes Enrollment of the | Paulness | investorshub | 04/19/2023 11:51:05 AM |
| NEWS -- Plus Therapeutics to Participate in Panel | Paulness | investorshub | 04/19/2023 12:00:25 AM |
| NEWS -- Plus Therapeutics Completes Phase 1/Part A | Paulness | investorshub | 04/18/2023 11:33:10 AM |
| May announce reverse split on 4/20? | Sierra20 | investorshub | 04/12/2023 1:57:16 PM |
| NEWS -- Plus Therapeutics to Announce First Quarter | Paulness | investorshub | 04/12/2023 12:52:45 PM |
| NEWS -- Plus Therapeutics Successfully Treats First Patient | Paulness | investorshub | 03/28/2023 12:08:15 PM |
| NEWS -- Plus Therapeutics Initiates Cohort 3 in | Paulness | investorshub | 03/22/2023 12:29:00 PM |
| NEWS -- Plus Therapeutics to Announce Fourth Quarter | Paulness | investorshub | 02/14/2023 1:04:46 PM |
| NEWS -- Plus Therapeutics Completes Enrollment in Second | Paulness | investorshub | 02/01/2023 1:09:27 PM |
| NEWS -- Plus Therapeutics Announces First Patient Dosed | Paulness | investorshub | 01/18/2023 1:30:59 PM |
| Nice PR this morning - Go $PSTV$$$$$ | The Ultimate Choice | investorshub | 01/18/2023 12:44:45 PM |
| znewcar1: $PSTV 23% v1,2M c.4782 f33,601M H.48 ML.29 | znewcar1 | investorshangout | 01/14/2023 4:14:28 AM |
| Almost Power Hour and we're at $.47 - | The Ultimate Choice | investorshub | 01/13/2023 7:50:07 PM |
| It appears we'll hit .44 in a few | The Ultimate Choice | investorshub | 01/13/2023 5:25:25 PM |
| Volume is up especially for a Friday - | The Ultimate Choice | investorshub | 01/06/2023 3:23:37 PM |
| Up .03 cents pre-market - Will there be | The Ultimate Choice | investorshub | 12/14/2022 2:19:53 PM |
| Great PR - hoping 4am tomorrow morning she | The Ultimate Choice | investorshub | 11/20/2022 3:47:13 PM |
| NEWS -- Plus Therapeutics Provides Updates on ReSPECT | Paulness | investorshub | 11/19/2022 5:49:58 PM |
| I think thats very possible. Analysts are very | skichic | investorshub | 11/18/2022 9:00:01 PM |
Stock Information
Get PSTV Alerts
News, Short Squeeze, Breakout and More Instantly...
PLUS THERAPEUTICS Inc. Company Name:
PSTV Stock Symbol:
NYSE Market:
Ad
-
Median overall survival (mOS) in 15 patients with recurrent glioblastoma (rGBM) from the Phase 2 study is 13 months, which is 63% better than current standard of care (bevacizumab monotherapy) of 8 months; 9 of the 15 patients remain alive Median progression free survival (mPFS) is 11 mon...
-
AUSTIN, Texas, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a clinical-stage pharmaceutical compa...
-
AUSTIN, Texas, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, today announced it ...